General dermatology
Human leucocyte antigen (HLA) testing can be carried out to identify patients who are at risk of severe cutaneous reactions to carbamazepine. This article asks the question of readers: if positive, which of the HLA alleles would suggest a risk of drug reaction with eosinophilia and systemic symptoms (DRESS) with carbamazepine use?
Authors
- Richard Watchorn (ORCID: https://orcid.org/0000-0001-8337-2501)
- Emda Orr (ORCID: https://orcid.org/0000-0001-6253-7004)
- Nicholas Stefanovic (ORCID: https://orcid.org/0000-0001-8751-4634)
Institutions
- Beaumont Hospital (IE)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1093/ced/llaf091
- Citations
- 1
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.39